2BB score and signals
Serina Therapeutics Inc’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 4 | Very Low |
| Momentum | 38 | Weakening |
| Financial strength | 30 | Weak |
| Quality | 40 | Normal |
| Risk | 61 | High |
Company facts
| Headquarters | Huntsville, Alabama, United States |
| Founded | 2006 |
| Employees | 16 |
| 52-week range | $1.22 – $7.92 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.4949 | — | $0.00 |
| 2026-08-07 | — | -0.4697 | — | $0.00 |
| 2026-05-14 | -0.58 | -0.4444 | $0.00 | $0.00 |
| 2026-03-25 | -0.31 | -0.4646 | $0.00 | $0.00 |
Related companies
